Antushevich H, Wójcik M (2018) Review: apelin in disease. Clin Chim Acta 483:241–248. https://doi.org/10.1016/j.cca.2018.05.012

Article  CAS  PubMed  Google Scholar 

Antushevich H, Pawlina B, Kapica M et al (2013) Influence of fundectomy and intraperitoneal or intragastric administration of apelin on apoptosis, mitosis, and DNA repair enzyme OGG1,2 expression in adult rats gastrointestinal tract and pancreas. J Physiol Pharmacol 64:423–428

CAS  PubMed  Google Scholar 

Bakir M, Geyikoglu F, Koç K, Cerig S (2018) Therapeutic effects of oleuropein on cisplatin-induced pancreas injury in rats. J Cancer Res Ther 14:671–678. https://doi.org/10.4103/jcrt.JCRT

Article  CAS  PubMed  Google Scholar 

Basu L, Smith A, Rick K et al (2022) Cisplatin impairs mitochondrial function and insulin secretion in mouse islets. Can J Diabetes 46:30. https://doi.org/10.1016/j.jcjd.2022.09.087

Article  Google Scholar 

Cantley J (2014) The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm Genome 25:442–454. https://doi.org/10.1007/s00335-014-9538-7

Article  CAS  PubMed  Google Scholar 

Castan-Laurell I, Masri B, Valet P (2019) The apelin/APJ system as a therapeutic target in metabolic diseases. Expert Opin Ther Targets 23:215–225. https://doi.org/10.1080/14728222.2019.1561871

Article  CAS  PubMed  Google Scholar 

Castan-Laurell I, Dray C, Valet P (2021) The therapeutic potentials of apelin in obesity-associated diseases. Mol Cell Endocrinol 529:111278. https://doi.org/10.1016/j.mce.2021.111278

Article  CAS  PubMed  Google Scholar 

Chen H, Zheng C, Zhang X et al (2011) Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 32:1634–1639. https://doi.org/10.1016/j.peptides.2011.06.025

Article  CAS  PubMed  Google Scholar 

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378. https://doi.org/10.1016/j.ejphar.2014.07.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dasari S, Njiki S, Mbemi A et al (2022) Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci 23:1–25. https://doi.org/10.3390/ijms23031532

Article  CAS  Google Scholar 

Demiryilmaz I, Sener E, Cetin N et al (2013) A comparative investigation of biochemical and histopathological effects of thiamine and thiamine pyrophosphate on ischemia-reperfusion induced oxidative damage in rat ovarian tissue. Arch Pharm Res 36:1133–1139. https://doi.org/10.1007/s12272-013-0173-8

Article  CAS  PubMed  Google Scholar 

Drapper H, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzym 186:421–431

Article  Google Scholar 

Egawa-Takata T, Endo H, Fujita M et al (2010) Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer. Cancer Sci 101:2171–2178. https://doi.org/10.1111/j.1349-7006.2010.01670.x

Article  CAS  PubMed  Google Scholar 

El Bakary NM, Thabet NM, El Fatih NM et al (2021) Fucoxanthin alters the apelin-13/APJ pathway in certain organs of γ-irradiated mice. J Radiat Res 62:600–617. https://doi.org/10.1093/jrr/rraa141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang C, Lou D, Zhou L et al (2021) Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 42:1951–1969. https://doi.org/10.1038/s41401-021-00620-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng J, Zhao H, Du M, Wu X (2019) The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats. Peptides 114:1–7. https://doi.org/10.1016/j.peptides.2019.03.006

Article  CAS  PubMed  Google Scholar 

Gao LR, Zhang NK, Zhang Y et al (2019) Correction to: Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res Ther 10:1–14. https://doi.org/10.1186/s13287-018-1116-6

Article  Google Scholar 

Gemici C, Sargin M, Uygur-Bayramicli O et al (2013) Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancer. Radiother Oncol 107:195–199. https://doi.org/10.1016/j.radonc.2013.04.013

Article  PubMed  Google Scholar 

Gemici C, Yaprak G, Ozdemir S et al (2018) Volumetric decrease of pancreas after abdominal irradiation, it is time to consider pancreas as an organ at risk for radiotherapy planning 11 medical and health sciences 1103 clinical sciences. Radiat Oncol 13:1–7. https://doi.org/10.1186/s13014-018-1189-5

Article  CAS  Google Scholar 

Ghosh S (2019) Cisplatin: the first metal based anticancer drug. Bioorg Chem 88:102925. https://doi.org/10.1016/j.bioorg.2019.102925

Article  CAS  PubMed  Google Scholar 

Goldstein RS, Mayor GH, Gingerich RL et al (1983) The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function. Toxicol Appl Pharmacol 69:432–441. https://doi.org/10.1016/0041-008X(83)90266-1

Article  CAS  PubMed  Google Scholar 

Guo L, Li Q, Wang W et al (2009) Apelin inhibits insulin secretion in pancreatic β-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr Res 34:142–154. https://doi.org/10.3109/07435800903287079

Article  CAS  PubMed  Google Scholar 

Han S, Englander EW, Gomez GA et al (2013) Pancreatitis activates pancreatic apelin-APJ axis in mice. Am J Physiol Gastrointest Liver Physiol. https://doi.org/10.1152/ajpgi.00370.2012

Article  PubMed  PubMed Central  Google Scholar 

Han S, Englander EW, Gomez GA, Greeley GH (2017) Apelin regulates nuclear factor-κB’s involvement in the inflammatory response of pancreatitis. Pancreas 46:64–70. https://doi.org/10.1097/MPA.0000000000000740

Article  CAS  PubMed  Google Scholar 

Huang CY, Lin YS, Liu YH et al (2018) Hyperglycemia crisis in head and neck cancer patients with platinum-based chemotherapy. J Chin Med Assoc 81:1060–1064. https://doi.org/10.1016/j.jcma.2018.05.008

Article  PubMed  Google Scholar 

Kapica M, Jankowska A, Antushevich H et al (2012) The effect of exogenous apelin on the secretion of pancreatic juice in anaesthetized rats. J Physiol Pharmacol 63:53–60

CAS  PubMed  Google Scholar 

Keskin-Aktan A, Kutlay Ö (2023) Exogenous apelin-13 administration ameliorates cyclophosphamide-induced oxidative stress, inflammation, and apoptosis in rat lungs. Protein Pept Lett 2023:743–753. https://doi.org/10.2174/0929866530666230824142516

Article  CAS  Google Scholar 

Li W, Zhu C, Liu T et al (2020) Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats. Diabetes Vasc Dis Res. https://doi.org/10.1177/1479164120966998

Article  Google Scholar 

Li B, Yin J, Chang J et al (2021) Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction. J Endocrinol 249:1–18. https://doi.org/10.1530/JOE-20-0398

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Cheng H, Adhikari BK et al (2022a) The role of apelin–APJ system in diabetes and obesity. Front Endocrinol (Lausanne) 13:1–11. https://doi.org/10.3389/fendo.2022.820002

Article  Google Scholar 

Li T, Bou-Dargham MJ, Fultang N et al (2022b) c-Rel-dependent monocytes are potent immune suppressor cells in cancer. J Leukoc Biol 112:845–859. https://doi.org/10.1002/JLB.1MA0422-518RR

Article  CAS  PubMed  Google Scholar 

Masoumi J, Jafarzadeh A, Khorramdelazad H et al (2020) Role of apelin/APJ axis in cancer development and progression. Adv Med Sci 65:202–213. https://doi.org/10.1016/j.advms.2020.02.002

Article  CAS  PubMed  Google Scholar 

Mercantepe F, Mercantepe T, Topcu A et al (2018) Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-018-1514-4

Article  PubMed  Google Scholar 

Mercantepe F, Mercantepe T, Topcu A et al (2019) Correction to: Protective effects of amifostine, curcumin and melatonin against cisplatin-induced acute kidney injury (Naunyn-Schmiedeberg’s Archives of Pharmacology, (2018), 391(9):915–931), 10.1007/s00210-018-1514-4). Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-019-01633-2

Article  PubMed  Google Scholar 

Minniti G, Goldsmith C, Brada M (2012) Radiotherapy. Handb Clin Neurol 104:215–228. https://doi.org/10.1016/B978-0-444-52138-5.00016-5

Article  PubMed  Google Scholar 

Moreno C, Nicaise C, Gustot T et al (2006) Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 291:1089–1099. https://doi.org/10.1152/ajpgi.00571.2005

Article  CAS